A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
The sub-tropics and the Arctic are rarely discussed together, and comparing shared experiences is expected to unlock new insights and generate a blueprint for solutions and adaptation.
A professor has identified 55 drug targets for the Zika virus from the human genome, leading to the identification of 79 FDA-approved drugs currently being used to treat other conditions such as cancer.
Research funded by a grant from the Bonefish & Tarpon Trust will design and test experimental means of growning bonefish for stock enhancement.
A psychology professor will continue a unique longitudinal study of bilingual development in children, focusing on language, literacy, cognitive growth, and academic achievement for Spanish-speaking children.
Where to live can be a dilemma for many Americans. A new FAU study is the first to evaluate the affordability of the U.S. Department of Housing and Urban Development (HUD) Section 8 Multifamily recipients.
Fruit flies can tell us a lot about sleep deprivation and metabolic disorders. A study is the first to show that a conserved gene - translin - works as a modulator of sleep in response to metabolic changes.
A new study by researchers at FAU and their collaborators has revealed a dramatic decline in the number of adult Americans who pray or believe in God, hitting an all-time low in 2014.
The "love" hormone, oxytocin, is an indispensable part of childbirth and mother-child bonding. A new study at FAU is looking at how a mother's levels of oxytocin might be different in women with depression.